BeOne Medicines Ltd. — Director's Dealing 2019

Nov 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-11-04

Reporting Person: Chen Timothy Yung-Cheng (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-04	American Depositary Shares	M	4000	$41.01	Acquired	4000	Direct
2019-11-04	American Depositary Shares	S	1200	$189.3697	Disposed	2800	Direct
2019-11-04	American Depositary Shares	S	1394	$190.3427	Disposed	1406	Direct
2019-11-04	American Depositary Shares	S	1306	$191.3185	Disposed	100	Direct
2019-11-04	American Depositary Shares	S	100	$192.18	Disposed	0	Direct
2019-11-05	American Depositary Shares	M	4000	$41.01	Acquired	4000	Direct
2019-11-05	American Depositary Shares	S	200	$187.3778	Disposed	3800	Direct
2019-11-05	American Depositary Shares	S	1500	$188.7132	Disposed	2300	Direct
2019-11-05	American Depositary Shares	S	1892	$189.5559	Disposed	408	Direct
2019-11-05	American Depositary Shares	S	208	$190.323	Disposed	200	Direct
2019-11-04	American Depositary Shares	S	200	$192.0563	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-04	Share Option (Right to Buy)	$3.16	M	52000	Acquired	2027-06-01	Ordinary Shares (52000.0)	Direct
2019-11-05	Share Option (Right to Buy)	$3.16	M	52000	Acquired	2027-06-01	Ordinary Shares (52000.0)	Direct

Footnotes

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.92 to $189.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.95 to $190.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.97 to $191.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.89 to $187.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.07 to $189.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.07 to $190.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.15 to $190.9450, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.42 to $192.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.

F11: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F12: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise.